PAREXEL® Access eHub:

Value Through Evidence

Back to Content Hub

A hybrid approach to post-approval research

You’ve made it through regulatory approvals. But is your pharmaceutical product actually positioned for market success? Even with regulatory approval, new drugs are still failing to secure reimbursement from payers and health technology assessment bodies at an alarmingly high rate. That means you need to further prove the value of your product.


This 2-minute video shows how PAREXEL’s Real-World Evidence ecosystem delivers the capability to use site-based research combined with healthcare databases, including linked EHR and claims data to help you:


1. Create average cost savings of 20%

2. Leverage real-world data assets on a global scale by augmenting existing data assets with site-based research activities

3. More effectively generate evidence to satisfy payers’ and providers’ requirement for real-world data


Video: A Hybrid Approach to Post-Approval Research

Share this: